MedPath

CKD-846

Generic Name
CKD-846

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

Phase 1
Recruiting
Conditions
Benign Prostate Hypertrophy(BPH)
Interventions
Drug: D091
First Posted Date
2023-11-01
Last Posted Date
2024-05-23
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
40
Registration Number
NCT06110923
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath